NORTH RUN CAPITAL, LP MaxCyte, Inc. Transaction History

NORTH RUN CAPITAL, LP portfolio value:

$3.62M
portfolio value

NORTH RUN CAPITAL, LP quarter portfolio value change:

+37.42%
quarter

MaxCyte, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -12.83% -82K shares 598K $6.5 556.96K
Q2 2022 share Increase +32.87% 158.06K shares -339K $4.73 638.96K
Q1 2022 share Increase 0.00% 480.9K shares 3.36M $6.99 480.9K